Mitsubishi UFJ Asset Management Co. Ltd. Raises Stake in Axon Enterprise, Inc $AXON

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 11.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,208 shares of the biotechnology company’s stock after buying an additional 18,679 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Axon Enterprise were worth $99,284,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Stone House Investment Management LLC purchased a new stake in Axon Enterprise in the third quarter worth approximately $29,000. New Millennium Group LLC purchased a new stake in Axon Enterprise in the third quarter worth approximately $29,000. Darwin Wealth Management LLC purchased a new stake in Axon Enterprise in the second quarter worth approximately $37,000. Root Financial Partners LLC purchased a new stake in Axon Enterprise in the third quarter worth approximately $34,000. Finally, Sound Income Strategies LLC boosted its stake in Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $426.89 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The stock has a 50 day moving average price of $451.93 and a two-hundred day moving average price of $527.52. The company has a market capitalization of $34.39 billion, a P/E ratio of 171.44, a PEG ratio of 8.24 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a return on equity of 3.95% and a net margin of 6.90%.The business’s revenue was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.47 earnings per share. Analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on AXON. Needham & Company LLC cut their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research note on Friday, February 20th. UBS Group lowered their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating for the company in a research report on Thursday. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a research report on Wednesday, February 25th. Craig Hallum reiterated a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Sixteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $722.69.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Company raised 2026 revenue growth guidance to 30%–32% and is targeting about $450M in free cash flow, signaling stronger cash conversion and confidence in demand. Axon raises 2026 revenue growth outlook to 30%-32% while targeting about
• Positive Sentiment: AI and counter‑drone businesses surged: AI product revenue reported up ~700% Y/Y and counter‑drone bookings/revenue rose several hundred percent, providing a new, high‑growth revenue stream beyond Taser and cameras. Axon Raises Guidance With AI Revenue Up 700%
• Positive Sentiment: Q1 revenue beat: revenue of ~$807M (+34% Y/Y) and strong bookings/ARR commentary underpin the company’s claim of durable growth across software, devices and international markets. Axon reports Q1 2026 revenue of $807 million, up 34% year over year
• Positive Sentiment: Analyst bullishness: JPMorgan raised its price target and kept an overweight stance, reflecting confidence from at least one major sell‑side shop. Benzinga: JPMorgan raises PT to $755
• Neutral Sentiment: Some brokers maintained Buy ratings and high targets (Needham, William Blair), signalling continued conviction but no consensus on valuation. Axon Maintained at Buy as Strong Growth Outlook Supports Unchanged $600 Price Target
• Neutral Sentiment: Media pieces are debating valuation — analysts’ average recommendations skew optimistic, so investors should weigh runway (AI/counter‑drone) against a stretched multiple. Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: EPS/margin noise: some reports flagged an EPS miss or tariff‑driven margin pressure despite revenue strength, which tempers the beat and raises near‑term margin visibility concerns. AXON Q1 Earnings Miss Estimates on Tariff-Driven Margins
• Negative Sentiment: Some firms trimmed price targets (Citizens/JMP, Piper Sandler lowered targets), reflecting divergent views on valuation and risk — a potential headwind for sentiment. Citizens Jmp lowers PT (TickerReport) Piper Sandler lowers PT (TickerReport)
• Negative Sentiment: Market reaction was mixed—some coverage notes shares slipped at times despite the beat, showing investors are parsing margins, guidance details and valuation. Axon Shares Slip Despite Q1 Results Above Expectations

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 157 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares in the company, valued at $567,910. This represents a 11.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Erika Nardini sold 198 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the transaction, the director owned 1,946 shares of the company’s stock, valued at approximately $985,804.68. This represents a 9.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 13,855 shares of company stock valued at $7,109,828 over the last 90 days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.